NASDAQ:CUR

Neuralstem News Headlines

Notice: This company has been marked as potentially delisted and may not be actively trading.
$2.93
-0.23 (-7.28 %)
(As of 07/30/2021 12:00 AM ET)
Add
Compare
Today's Range
$2.82
$3.09
50-Day Range
$0.67
$1.52
52-Week Range
$1.10
$13.78
Volume935,985 shs
Average Volume236,278 shs
Market Capitalization$6.15 million
P/E RatioN/A
Dividend YieldN/A
Beta1.81

Neuralstem (NASDAQ CUR) News Headlines Today

SourceHeadline
Life sciences startups a focus of Capital Region economic development - Albany Business Review - Albany Business ReviewLife sciences startups a focus of Capital Region economic development - Albany Business Review - Albany Business Review
bizjournals.com - July 27 at 1:59 PM
Maybe GameStop Is Good Now - BloombergMaybe GameStop Is Good Now - Bloomberg
bloomberg.com - June 10 at 1:00 PM
2021 Major Depressive Disorder Pipeline Insight Report: Insights for Approx 50+ Companies and 50+ Pipeline Drugs - ResearchAndMarkets.com - Business Wire2021 Major Depressive Disorder Pipeline Insight Report: Insights for Approx 50+ Companies and 50+ Pipeline Drugs - ResearchAndMarkets.com - Business Wire
businesswire.com - June 10 at 8:00 AM
EOG Resources names insider Yacob as CEO - Yahoo FinanceEOG Resources names insider Yacob as CEO - Yahoo Finance
finance.yahoo.com - June 8 at 1:19 PM
A Former Restaurant Critic Shares 11 Tips for Dining Out - Yahoo FinanceA Former Restaurant Critic Shares 11 Tips for Dining Out - Yahoo Finance
finance.yahoo.com - June 8 at 8:19 AM
Neuralstem Worker Tipped Partner to Trial Results, SEC Says - BloombergNeuralstem Worker Tipped Partner to Trial Results, SEC Says - Bloomberg
bloomberg.com - June 7 at 7:28 PM
Accumulating Evidence Suggests E-Cigarettes Are Likely As Harmful To The Brain As Regular Smoking - ForbesAccumulating Evidence Suggests E-Cigarettes Are Likely As Harmful To The Brain As Regular Smoking - Forbes
forbes.com - June 6 at 11:47 PM
The Stem Cell Manufacturing market is projected to reach USD 18.0 billion by 2026 from USD - GlobeNewswireThe Stem Cell Manufacturing market is projected to reach USD 18.0 billion by 2026 from USD - GlobeNewswire
globenewswire.com - May 27 at 12:58 PM
Global Gene and Cell Therapies Targeting CNS Disorders Market 2021-2026 Featuring Emerging Drugs - GlobeNewswireGlobal Gene and Cell Therapies Targeting CNS Disorders Market 2021-2026 Featuring Emerging Drugs - GlobeNewswire
globenewswire.com - May 26 at 2:14 PM
Global Gene and Cell Therapies Targeting CNS Disorders Market 2021-2026 Featuring Emerging Drugs - NurOwn (BrainStorm Cell Therapeutics) & Neuro-Cells (Neuroplast) - BenzingaGlobal Gene and Cell Therapies Targeting CNS Disorders Market 2021-2026 Featuring Emerging Drugs - NurOwn (BrainStorm Cell Therapeutics) & Neuro-Cells (Neuroplast) - Benzinga
benzinga.com - May 26 at 8:42 AM
Curative Biotechnology, Inc. Files 2021 First Quarter Financials and Issues Letter to Shareholders - GlobeNewswireCurative Biotechnology, Inc. Files 2021 First Quarter Financials and Issues Letter to Shareholders - GlobeNewswire
globenewswire.com - May 25 at 10:02 AM
Forma Therapeutics Holdings (FMTX) to Present Data from Pivotal Phase 2 Trial of Olutasidenib at ASCO - StreetInsider.comForma Therapeutics Holdings (FMTX) to Present Data from Pivotal Phase 2 Trial of Olutasidenib at ASCO - StreetInsider.com
streetinsider.com - May 20 at 8:47 AM
Tellus Therapeutics Secures Seed Financing to Develop the First Treatment for Newborns with White Matter Brain Injury - StreetInsider.comTellus Therapeutics Secures Seed Financing to Develop the First Treatment for Newborns with White Matter Brain Injury - StreetInsider.com
streetinsider.com - May 12 at 11:08 AM
Neural Stem Cell Institute and Yuyang DNU form Luxa Biotechnology - Albany Business Review - Albany Business ReviewNeural Stem Cell Institute and Yuyang DNU form Luxa Biotechnology - Albany Business Review - Albany Business Review
bizjournals.com - April 22 at 5:50 PM
AIM WINNERS & LOSERS: Futura Medical up on EU medical device clearance - MorningstarAIM WINNERS & LOSERS: Futura Medical up on EU medical device clearance - Morningstar
morningstar.co.uk - March 19 at 8:31 AM
Connectyx Announces Key Biotech Industry Veterans to Management Team - StreetInsider.comConnectyx Announces Key Biotech Industry Veterans to Management Team - StreetInsider.com
streetinsider.com - February 11 at 5:44 PM
Connectyx names - Seeking AlphaConnectyx names - Seeking Alpha
seekingalpha.com - February 11 at 12:44 PM
Global Cell Therapy Market (2020 to 2027) - by Cell Type, Therapy Type, Therapeutic Area, and End-user - ResearchAndMarkets.com - Business WireGlobal Cell Therapy Market (2020 to 2027) - by Cell Type, Therapy Type, Therapeutic Area, and End-user - ResearchAndMarkets.com - Business Wire
businesswire.com - February 10 at 3:10 PM
Outlook on the Cell Therapy Global Market to 2027 - Opportunity Analysis and Industry Forecasts - Yahoo FinanceOutlook on the Cell Therapy Global Market to 2027 - Opportunity Analysis and Industry Forecasts - Yahoo Finance
finance.yahoo.com - February 10 at 10:09 AM
Stem Cell Therapy Market Size to Reach USD 5,040 Million by 2028 | Rising Public-Private Investments and Developing Regulatory Framework for Stem Cell Therapeutics will be the Key Factor Driving the Industry Growth, States Emergen Research - Yahoo FinanceStem Cell Therapy Market Size to Reach USD 5,040 Million by 2028 | Rising Public-Private Investments and Developing Regulatory Framework for Stem Cell Therapeutics will be the Key Factor Driving the Industry Growth, States Emergen Research - Yahoo Finance
finance.yahoo.com - January 29 at 9:04 AM
Form 425 Seneca Biopharma, Inc. Filed by: Seneca Biopharma, Inc. - StreetInsider.comForm 425 Seneca Biopharma, Inc. Filed by: Seneca Biopharma, Inc. - StreetInsider.com
streetinsider.com - January 22 at 9:19 AM
Form SC 13G/A Seneca Biopharma, Inc. Filed by: SABBY MANAGEMENT, LLC - StreetInsider.comForm SC 13G/A Seneca Biopharma, Inc. Filed by: SABBY MANAGEMENT, LLC - StreetInsider.com
streetinsider.com - January 8 at 1:35 PM
Formas olutasidenib shows positive action in mid-stage leukemia study - Seeking AlphaForma's olutasidenib shows positive action in mid-stage leukemia study - Seeking Alpha
seekingalpha.com - October 26 at 9:10 AM
Form 8-K NovAccess Global Inc. For: Oct 15 - StreetInsider.comForm 8-K NovAccess Global Inc. For: Oct 15 - StreetInsider.com
streetinsider.com - October 22 at 12:49 AM
NovAccess Global Appoints Dwain Irvin, Ph.D., MPH as New Chief Executive Officer - StreetInsider.comNovAccess Global Appoints Dwain Irvin, Ph.D., MPH as New Chief Executive Officer - StreetInsider.com
streetinsider.com - October 16 at 9:29 AM
NovAccess Global Appoints Dwain Irvin, Ph.D., MPH as New Chief Executive Officer - Yahoo FinanceNovAccess Global Appoints Dwain Irvin, Ph.D., MPH as New Chief Executive Officer - Yahoo Finance
finance.yahoo.com - October 15 at 1:21 PM
Amyotrophic Lateral Sclerosis (ALS) Markets - $1.04 Billion Opportunity Analysis and Forecasts to 2029: Biogen, Mitsubishi, and BrainStorm are Forecast to Lead the ALS Market - ResearchAndMarkets.com - Business WireAmyotrophic Lateral Sclerosis (ALS) Markets - $1.04 Billion Opportunity Analysis and Forecasts to 2029: Biogen, Mitsubishi, and BrainStorm are Forecast to Lead the ALS Market - ResearchAndMarkets.com - Business Wire
businesswire.com - October 5 at 2:32 PM
Letter from Seneca Biopharma's Executive ChairmanLetter from Seneca Biopharma's Executive Chairman
finance.yahoo.com - September 2 at 12:01 PM
CurePSP Partners With Rainwater to Support Pioneering Neurodegeneration Research - Yahoo FinanceCurePSP Partners With Rainwater to Support Pioneering Neurodegeneration Research - Yahoo Finance
finance.yahoo.com - August 12 at 1:29 PM
ReNeuron encouraged by progress in stroke and RP treatments - Proactive Investors USA & CanadaReNeuron encouraged by progress in stroke and RP treatments - Proactive Investors USA & Canada
www.proactiveinvestors.com - June 2 at 5:43 PM
Connectyx Welcomes I. Richard Garr, Esq. to Companys Scientific Advisory Board - GlobeNewswireConnectyx Welcomes I. Richard Garr, Esq. to Company's Scientific Advisory Board - GlobeNewswire
www.globenewswire.com - May 19 at 5:02 PM
Connectyx Welcomes I. Richard Garr, Esq. to Company’s Scientific Advisory Board - Yahoo FinanceConnectyx Welcomes I. Richard Garr, Esq. to Company’s Scientific Advisory Board - Yahoo Finance
finance.yahoo.com - May 19 at 12:02 PM
Stem Cells Market To Reach USD 17.78 Billion By 2027 | Reports and Data - GlobeNewswireStem Cells Market To Reach USD 17.78 Billion By 2027 | Reports and Data - GlobeNewswire
www.globenewswire.com - May 4 at 4:17 PM
ReNeuron Announces Exosome Research Collaboration - Yahoo FinanceReNeuron Announces Exosome Research Collaboration - Yahoo Finance
finance.yahoo.com - April 8 at 7:50 AM
AgeX Therapeutics Reports Fourth Quarter and Annual 2019 Financial Results and Provides Business Update - Business WireAgeX Therapeutics Reports Fourth Quarter and Annual 2019 Financial Results and Provides Business Update - Business Wire
www.businesswire.com - March 30 at 9:05 PM
Stem cell-combo therapy could bring long-term relief for gastroparesis - Yahoo FinanceStem cell-combo therapy could bring long-term relief for gastroparesis - Yahoo Finance
finance.yahoo.com - March 18 at 11:42 PM
Growth factor-modified stem cells help repair spinal cord injuries in rats - Yahoo FinanceGrowth factor-modified stem cells help repair spinal cord injuries in rats - Yahoo Finance
finance.yahoo.com - February 19 at 12:30 PM
AgeX Therapeutics to Collaborate with University of California, Irvine on Neural Stem Cell Research Program for Huntington’s Disease and Other Neurological Disorders - Yahoo FinanceAgeX Therapeutics to Collaborate with University of California, Irvine on Neural Stem Cell Research Program for Huntington’s Disease and Other Neurological Disorders - Yahoo Finance
finance.yahoo.com - February 3 at 12:24 PM
Form 8-K Neuralstem, Inc. For: Jan 23 - StreetInsider.comForm 8-K Neuralstem, Inc. For: Jan 23 - StreetInsider.com
www.streetinsider.com - January 23 at 1:18 PM
Seneca Biopharma rockets 129% on cell therapy promise - Seeking AlphaSeneca Biopharma rockets 129% on cell therapy promise - Seeking Alpha
seekingalpha.com - January 17 at 12:57 PM
Neuralstem Stock Plunges After Latest Study on ALS DrugNeuralstem Stock Plunges After Latest Study on ALS Drug
www.thestreet.com - November 24 at 8:54 AM
Form 8-K Neuralstem, Inc. For: Nov 14 - StreetInsider.comForm 8-K Neuralstem, Inc. For: Nov 14 - StreetInsider.com
www.streetinsider.com - November 15 at 5:29 PM
Form 10-Q Neuralstem, Inc. For: Sep 30 - StreetInsider.comForm 10-Q Neuralstem, Inc. For: Sep 30 - StreetInsider.com
www.streetinsider.com - November 14 at 11:24 AM
Todays Top 5 Gainers In Healthcare Sector (ISEE, ZEAL, CUR…)Today's Top 5 Gainers In Healthcare Sector (ISEE, ZEAL, CUR…)
markets.businessinsider.com - November 1 at 7:05 PM
Neuralstem leads healthcare gainers; Cyclerion Therapeutics tops the losers - Seeking AlphaNeuralstem leads healthcare gainers; Cyclerion Therapeutics tops the losers - Seeking Alpha
seekingalpha.com - October 30 at 1:57 PM
Seneca Biopharma up 47% on expected pipeline expansion - Seeking AlphaSeneca Biopharma up 47% on expected pipeline expansion - Seeking Alpha
seekingalpha.com - October 30 at 1:57 PM
Seneca Biopharma and QYuns Therapeutics Sign Term Sheet for Global Licensing of Novel Monoclonal Antibodies for Treating Auto-Immune DiseasesSeneca Biopharma and QYuns Therapeutics Sign Term Sheet for Global Licensing of Novel Monoclonal Antibodies for Treating Auto-Immune Diseases
finance.yahoo.com - October 30 at 8:57 AM
Local biopharma rebrands as part of commercialization strategy - Washington Business JournalLocal biopharma rebrands as part of commercialization strategy - Washington Business Journal
www.bizjournals.com - October 29 at 11:22 PM
Local biopharma rebrands as part of commercialization strategyLocal biopharma rebrands as part of commercialization strategy
finance.yahoo.com - October 29 at 6:22 PM
Seneca Biopharma to Present at the 7th China Renaissance Healthcare and Life Sciences Leadership SummitSeneca Biopharma to Present at the 7th China Renaissance Healthcare and Life Sciences Leadership Summit
finance.yahoo.com - October 28 at 11:28 PM
This page was last updated on 8/1/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.